Sara earned her Ph.D. from the City University of New York Graduate Center in Biology, where she studied Developmental Neurotoxicology. She currently works as a Research Scientist, Professor, and School Administrator in New York City.
As a result of significant reductions in walking and physical therapy, people with Charcot-Marie-Tooth (CMT) disease reported worsening physical skills and pain scores after the COVID-19 lockdowns, a recent survey ... Read more
The CMT Research Foundation has launched a new research program that will seek to develop a precision medicine approach to treat people with Charcot-Marie-Tooth (CMT) disease, the foundation announced in ... Read more
Patients with Charcot Marie Tooth Type 1A (CMT1A) disease appear to experience a structural reorganization in their brains, particularly in a region associated with movement and balance called the cerebellum, ... Read more
A new formulation of an antioxidant called curcumin may be effective in alleviating the symptoms of Charcot-Marie-Tooth type 1A (CMT1A) disease, a rat study suggests. The formulation was seen to ... Read more
The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has awarded DTx Pharma a funding grant to advance development of promising new therapeutic candidates ... Read more
Three new genetic mutations in the GJB1 gene have been found inn Chinese patients that can cause X-linked Charcot-Marie-Tooth (CMTX1) disease, expanding the diversity of mutations causing the condition, according ... Read more